gbfi

Reagena has released for sale a rapid test for the determination of chemokine CXCL13 in human cerebrospinal fluid

ReaScan CXCL13 is a CE marked easy-to-use, fast and effective test supporting the early diagnosis of Lyme neuroborreliosis (LNB).

Learn more: ReaScan CXCL13

Got interested? Please contact info@reagena.com.